Search hospitals > Nevada > Henderson
OptumCare Cancer Care at Seven Hills
Claim this profileHenderson, Nevada 89052
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Tumors
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
144 reported clinical trials
2 medical researchers
Summary
OptumCare Cancer Care at Seven Hills is a medical facility located in Henderson, Nevada. This center is recognized for care of Cancer, Breast Cancer, Tumors, Lung Cancer, Adenocarcinoma and other specialties. OptumCare Cancer Care at Seven Hills is involved with conducting 144 clinical trials across 305 conditions. There are 2 research doctors associated with this hospital, such as John A. Ellerton and Alan K. Ikeda.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
John A. EllertonOptumCare Cancer Care at Fort Apache4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
151 reported clinical trials
229 drugs studied
Alan K. IkedaAlliance for Childhood Diseases/Cure 4 the Kids Foundation7 years of reported clinical research
Expert in Tumors
Expert in Leukemia
53 reported clinical trials
110 drugs studied
Clinical Trials running at OptumCare Cancer Care at Seven Hills
Breast Cancer
Cancer
Bladder Cancer
Non-Small Cell Lung Cancer
Gastric Cancer
Lung Cancer
Bladder Carcinoma
Esophageal Cancer
Prostate Cancer
Tumors
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at OptumCare Cancer Care at Seven Hills?
OptumCare Cancer Care at Seven Hills is a medical facility located in Henderson, Nevada. This center is recognized for care of Cancer, Breast Cancer, Tumors, Lung Cancer, Adenocarcinoma and other specialties. OptumCare Cancer Care at Seven Hills is involved with conducting 144 clinical trials across 305 conditions. There are 2 research doctors associated with this hospital, such as John A. Ellerton and Alan K. Ikeda.